# AQUESTIVE THERAPEUTICS INC (AQST)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/AQST/

- Reporting holders: 5
- Reported value: $109.8K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Adirondack Capital Advisors, LLC](https://holderbook.com/funds/2107623-adirondack-capital-advisors-llc/) | $55.6K | 12,000 | 0.0% | 3 |
| [Cox Capital Mgt LLC](https://holderbook.com/funds/1748728-cox-capital-mgt-llc/) | $48.6K | 10,500 | 0.0% | 5 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $3.5K | 750 | 0.0% | 4 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $2.1K | 463 | 0.0% | 4 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $56 | 12 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $109.8K |
| Q2 2026 | 190 | $326.6M |
| Q1 2026 | 183 | $314.6M |
| Q4 2025 | 189 | $491.7M |
| Q3 2025 | 155 | $382.5M |
| Q2 2025 | 117 | $160.7M |
| Q1 2025 | 121 | $103.7M |
| Q4 2024 | 114 | $158.3M |
| Q3 2024 | 116 | $241.4M |
| Q2 2024 | 98 | $87.8M |
| Q1 2024 | 98 | $184.2M |
| Q4 2023 | 58 | $28.8M |